Vidac Pharma   Report issue

For profit Phase 2
Founded: Jerusalem Israel (2011)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2016
NCT02844777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Vidac Pharma

Active Ingredients

Drugs in Phase 2 Trials (1)

vda-1102 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1